ZA921039B - New pharmaceutical use of fused tetrahydropyridine derivatives - Google Patents

New pharmaceutical use of fused tetrahydropyridine derivatives

Info

Publication number
ZA921039B
ZA921039B ZA921039A ZA921039A ZA921039B ZA 921039 B ZA921039 B ZA 921039B ZA 921039 A ZA921039 A ZA 921039A ZA 921039 A ZA921039 A ZA 921039A ZA 921039 B ZA921039 B ZA 921039B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical use
new pharmaceutical
tetrahydropyridine derivatives
fused tetrahydropyridine
fused
Prior art date
Application number
ZA921039A
Inventor
Walter Loesel
Loesel Walter
Otto Roos
Roos Otto
Dietrich Arndts
Arndts Dietrich
Guenter Schingnitz
Schingnitz Guenter
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of ZA921039B publication Critical patent/ZA921039B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ZA921039A 1991-02-13 1992-02-12 New pharmaceutical use of fused tetrahydropyridine derivatives ZA921039B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4104257A DE4104257A1 (en) 1991-02-13 1991-02-13 USE OF ANALYZED TETRAHYDROPYRIDINE IGNESE DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL ILLNESSES

Publications (1)

Publication Number Publication Date
ZA921039B true ZA921039B (en) 1992-09-30

Family

ID=6424901

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA921039A ZA921039B (en) 1991-02-13 1992-02-12 New pharmaceutical use of fused tetrahydropyridine derivatives

Country Status (6)

Country Link
AU (1) AU1199092A (en)
DE (1) DE4104257A1 (en)
IE (1) IE920451A1 (en)
IL (1) IL100927A0 (en)
WO (1) WO1992014465A1 (en)
ZA (1) ZA921039B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2724384B1 (en) * 1994-09-14 1999-04-16 Cemaf NOVEL 3,4-DIHYDRO BETA-CARBOLINE DERIVATIVES OF MELATONIN AGONISTS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS
WO2000051998A1 (en) 1999-03-02 2000-09-08 Boehringer Ingelheim Pharmaceuticals, Inc. Compounds useful as reversible inhibitors of cathepsin s
CA2367138C (en) * 1999-03-24 2010-10-05 Alejandro M. S. Mayer Anti-inflammatory uses of manzamines
US6420364B1 (en) 1999-09-13 2002-07-16 Boehringer Ingelheim Pharmaceuticals, Inc. Compound useful as reversible inhibitors of cysteine proteases
NZ533358A (en) * 2001-12-19 2007-05-31 Lundbeck & Co As H 3,4-Dihydro-1H-isoquinolin-2-yl-derivatives for use as NK2 receptor antagonists
TW201038569A (en) * 2009-02-16 2010-11-01 Abbott Gmbh & Co Kg Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy
SG181498A1 (en) 2009-12-04 2012-07-30 Sunovion Pharmaceuticals Inc Multicyclic compounds and methods of use thereof
WO2018023072A2 (en) 2016-07-29 2018-02-01 Sunovion Pharmaceuticals, Inc. Compounds and compositions and uses thereof
EP3490607A4 (en) 2016-07-29 2020-04-08 Sunovion Pharmaceuticals Inc. Compounds and compositions and uses thereof
EP3582815A1 (en) 2017-02-16 2019-12-25 Sunovion Pharmaceuticals Inc. Methods of treating schizophrenia
JP7191085B2 (en) 2017-08-02 2022-12-16 サノビオン ファーマシューティカルズ インク Isochroman compounds and uses thereof
US10815249B2 (en) 2018-02-16 2020-10-27 Sunovion Pharmaceuticals Inc. Salts, crystal forms, and production methods thereof
MX2021010880A (en) 2019-03-14 2022-01-18 Sunovion Pharmaceuticals Inc Salts of a isochromanyl compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereof.
CN115734785A (en) 2020-04-14 2023-03-03 桑诺维恩药品公司 (S) - (4, 5-dihydro-7H-thieno [2,3-c ] pyran-7-yl) -N-methylmethanamine for the treatment of neurological and psychiatric disorders

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3021331A (en) * 1959-07-20 1962-02-13 Pfizer & Co C Azabenzopyridocolines
FR2455044A1 (en) * 1979-04-26 1980-11-21 Synthelabo PYRIDO-INDOLES AND THEIR APPLICATION IN THERAPEUTICS
IL86131A0 (en) * 1987-04-24 1988-11-15 Boehringer Ingelheim Kg Benzo-and thieno-3,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
DE3827727A1 (en) * 1988-08-16 1990-02-22 Boehringer Ingelheim Kg ANALYZED TETRAHYDROPYRIDINE IGNESE DERIVATIVES, METHOD FOR THE PRODUCTION AND USE OF SUCH CONNECTIONS FOR CARDIRO PROTECTION
CA2000901A1 (en) * 1988-10-21 1990-04-21 Alexis A. Cordi Phosphono-hydroisoquinoline compounds useful in reducing neurotoxic injury
JPH03109385A (en) * 1989-09-22 1991-05-09 Fujisawa Pharmaceut Co Ltd New tricyclic amine compound and salt thereof
AU6368090A (en) * 1989-10-03 1991-04-11 Warner-Lambert Company Substituted carboxytetrahydroisoquinolines and derivatives thereof having pharmaceutical activity

Also Published As

Publication number Publication date
IE920451A1 (en) 1992-08-12
DE4104257A1 (en) 1992-08-20
WO1992014465A1 (en) 1992-09-03
IL100927A0 (en) 1992-11-15
AU1199092A (en) 1992-09-15

Similar Documents

Publication Publication Date Title
IL103748A0 (en) 2-substituted saccharin derivatives and pharmaceutical compositions containing them
EP0428268A3 (en) Pharmaceutical phenylpyridone derivatives
IL88988A0 (en) Didehydro-vitamin d3 derivatives and pharmaceutical compositions containing them
GB2255503B (en) Improved use of ß2-bronchodilator drugs
NZ224129A (en) Cephalosporin derivatives and pharmaceutical compositions
EP0498268A3 (en) 5-oxo-l-proline derivatives and pharmaceutical use thereof
NZ237191A (en) 2-((substituted amide) substituted heterocyclylthio) carbpen-2-em derivatives and pharmaceutical compositions
NZ231487A (en) Pyridin-2-yl piperazine derivatives and pharmaceutical compositions
ZA921039B (en) New pharmaceutical use of fused tetrahydropyridine derivatives
IL103818A0 (en) Cephalosporin derivatives,their manufacture and pharmaceutical compositions containing them
IL90639A (en) Neplanocin derivatives and analogs and pharmaceutical compositions containing them
IL103747A0 (en) Saccharin derivatives and pharmaceutical compositions containing them
NZ224130A (en) Cephalosporin derivatives and pharmaceutical compositions
NZ233013A (en) Substituted thieno-triazolo-diazepine derivatives and pharmaceutical compositions
NZ225387A (en) Thienoimidazole derivatives and pharmaceutical compositions
NZ230927A (en) Substituted piperazine derivatives and therapeutic compositions
NZ228403A (en) Cephalosporin derivatives and pharmaceutical compositions
NZ225383A (en) Cephalosporin derivatives and pharmaceutical compositions
NZ239186A (en) Substituted 2-(9-fluorenonyl)-carbapenem derivatives and pharmaceutical
IL102539A0 (en) Preparation of 17beta-substituted-4-aza 5alpha-androstan-3-one derivatives
NZ209447A (en) Heterocyclic aminocyclopentane derivatives and pharmaceutical compositions
NZ241331A (en) 3-phenyl-2-alkenamide derivatives and pharmaceutical compositions thereof
NZ228281A (en) Tricyclo-amine derivatives and pharmaceutical compositions
ZA945651B (en) Use of benzenesulphonzlindole derivatives for the preparation of medicines
NZ224997A (en) Cephalosporin derivatives and pharmaceutical compositions